{"id":5078,"date":"2025-02-26T00:01:00","date_gmt":"2025-02-26T08:01:00","guid":{"rendered":"https:\/\/www.osmosis.org\/blog\/?p=5078"},"modified":"2025-11-04T16:05:47","modified_gmt":"2025-11-05T00:05:47","slug":"pance-question-of-the-day-sle-management","status":"publish","type":"post","link":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management","title":{"rendered":"PANCE\u00ae Question of the Day: SLE management"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_80 ez-toc-wrap-center counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">In This Article<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#Laboratory_Test_Results\" >Laboratory Test Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#The_correct_answer_to_todays_PANCE%C2%AE_Question_is%E2%80%A6\" >The correct answer to today\u2019s PANCE\u00ae Question is\u2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#Incorrect_Answer_Explanations\" >Incorrect Answer Explanations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#Main_Explanation\" >Main Explanation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#Major_Takeaway\" >Major Takeaway<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#References\" >References<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\/#Want_to_learn_more_about_this_topic\" >Want to learn more about this topic?<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p class=\"wp-block-paragraph\"><em>Prepare for the <strong>PANCE exam<\/strong> with this challenging clinical scenario that tests your ability to <strong>diagnose and manage<\/strong> a common yet serious condition.\u00a0Do you know the answer? Let&#8217;s find out!<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A <strong>24-year-old woman<\/strong> with a history of <strong>systemic lupus erythematosus (SLE)<\/strong> presents to the clinic with <strong>fatigue, joint pain,<\/strong> and a <strong>malar rash<\/strong> that has worsened over the past two weeks. She was diagnosed with SLE two years ago and takes <strong>hydroxychloroquine<\/strong> regularly. She has no shortness of breath or lower extremity swelling. Temperature is <strong>37.2\u00b0C (99.0\u00b0F)<\/strong>, heart rate is <strong>88\/min<\/strong>, blood pressure is <strong>130\/80 mmHg<\/strong>, respiratory rate is <strong>16\/min<\/strong>, and oxygen saturation is <strong>98% on room air.<\/strong> Physical examination is significant for a pronounced <strong>malar rash<\/strong> and <strong>bilateral joint swelling and tenderness<\/strong> in her wrists, hands, knees, and elbows. <strong>Laboratory test results<\/strong> are below.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Laboratory_Test_Results\"><\/span>Laboratory Test Results<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hemoglobin:<\/strong> 10.2 g\/dL (Reference range: 12\u201316 g\/dL)<br><strong>Hematocrit:<\/strong> 28% (Reference range: 36\u201346%)<br><strong>White blood cell count:<\/strong> 5,100 cells\/microL (Reference range: 4,500\u201311,000 cells\/microL)<br><strong>Platelet count:<\/strong> 35,000\/microL (Reference range: 150,000\u2013400,000\/microL)<br><strong>Reticulocyte count:<\/strong> 9% (Reference range: 0.5\u20131.5%)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mean corpuscular volume:<\/strong> 88 fL (Reference range: 80\u2013100 fL)<br><strong>Creatinine:<\/strong> 0.9 mg\/dL (Reference range: 0.6\u20131.2 mg\/dL)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Urinalysis:<\/strong><br><strong>Specific gravity:<\/strong> 1.010 (Reference range: 1.005\u20131.03)<br><strong>pH:<\/strong> 6.0 (Reference range: 4.5\u20138)<br><strong>Protein:<\/strong> Negative (Reference range: Negative)<br><strong>Blood:<\/strong> Negative (Reference range: Negative)<br><strong>Casts:<\/strong> None (Reference range: None)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Which of the following is the <em>best <\/em>next step in management?\u00a0<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A. Oral glucocorticoids<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>B. Increased dose of hydroxychloroquine<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>C. Cyclophosphamide<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>D. Belimumab<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>E. Angiotensin receptor blocker<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center wp-block-paragraph\"><em><strong>Scroll down to find the answer!<\/strong><\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"The_correct_answer_to_todays_PANCE%C2%AE_Question_is%E2%80%A6\"><\/span>The correct answer to today\u2019s PANCE\u00ae Question is\u2026<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A. Oral glucocorticoids&nbsp;&nbsp;<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Before we get to the <strong>Main Explanation<\/strong>, let\u2019s look at the <strong>incorrect answer explanations.<\/strong> Skip to the bottom if you want to see the correct answer right away!<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Incorrect_Answer_Explanations\"><\/span>Incorrect Answer Explanations<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>B. Increased dose of hydroxychloroquine<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rationale:<\/strong> While <strong>hydroxychloroquine<\/strong> is beneficial for <strong>long-term management<\/strong> of <strong>systemic lupus erythematosus<\/strong>, it does not provide immediate control of <strong>moderate disease flares.<\/strong> This patient&#8217;s worsening symptoms, especially the moderate hematologic abnormalities (i.e., thrombocytopenia), require the addition of a more <strong>potent, rapid-acting treatment<\/strong> like <strong>glucocorticoids.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>C. Cyclophosphamide<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rationale:<\/strong> <strong>Cyclophosphamide<\/strong> is indicated in <strong>severe, organ-threatening, and life-threatening cases<\/strong> of systemic lupus erythematosus (e.g., lupus nephritis). In a moderate flare without evidence of severe organ damage, as seen in this patient, the risks and side effects of cyclophosphamide outweigh its benefits.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>D. Belimumab<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rationale:<\/strong> <strong>Belimumab<\/strong> is an add-on therapy for patients with <strong>active systemic lupus erythematosus.<\/strong> It is not initially indicated to treat moderate disease flares. It is typically used when standard therapies fail to control symptoms. This patient&#8217;s flare, while moderate, can be managed effectively with standard treatment, such as <strong>medium-dose glucocorticoids.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>E. Angiotensin receptor blocker<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rationale:<\/strong> <strong>Angiotensin II receptor blockers<\/strong> are used to treat <strong>hypertension and renal disease<\/strong> in patients with systemic lupus erythematosus. This patient does not have evidence of <strong>lupus nephritis or hypertension.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Main_Explanation\"><\/span>Main Explanation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This patient with a history of <strong>systemic lupus erythematosus (SLE)<\/strong> presents with <strong>increased fatigue, extensive joint inflammation,<\/strong> a <strong>worsening malar rash, anemia,<\/strong> and <strong>moderate thrombocytopenia;<\/strong> indicating <strong>moderate disease severity.<\/strong> In addition to <strong>hydroxychloroquine, oral glucocorticoids (like prednisone)<\/strong> would be the preferred treatment for <strong>moderate disease activity without major organ-threatening disease.<\/strong> The <strong>potent anti-inflammatory and immunosuppressive effects of glucocorticoids<\/strong> can significantly reduce the symptoms of a lupus flare and prevent further progression of the disease.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Treatment for <strong>SLE<\/strong> depends on <strong>disease severity.<\/strong> All patients with SLE should be started on <strong>hydroxychloroquine<\/strong> due to its ability to <strong>reduce the frequency of flares<\/strong> and <strong>prevent long-term organ damage.<\/strong> For <strong>mild SLE flares<\/strong>, characterized by symptoms such as mild skin and joint involvement and mild cytopenias, hydroxychloroquine should be used and <strong>NSAIDs or low-dose glucocorticoids<\/strong> may be added. For <strong>moderate disease flares<\/strong>, which may present with more pronounced symptoms and moderate cytopenias, as seen in this patient, treatment includes the addition of <strong>oral moderate-dose glucocorticoids.<\/strong> If response is inadequate despite combined therapy, additional <strong>immunosuppressants (e.g., azathioprine, mycophenolate mofetil)<\/strong> are indicated. For <strong>severe SLE<\/strong> with <strong>organ-threatening complications<\/strong>, a more intensive treatment strategy is indicated. This consists of a combination of <strong>hydroxychloroquine, high-dose glucocorticoids,<\/strong> and <strong>immunosuppressive therapy<\/strong> (e.g., mycophenolate mofetil, cyclophosphamide). <strong>ACE inhibitors or angiotensin receptor blockers (ARBs)<\/strong> are also used to treat renal disease.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"975\" height=\"553\" src=\"https:\/\/hm-healthdigital-multisite.go-vip.net\/osmosisblog\/wp-content\/uploads\/sites\/2\/2025\/01\/image_e05534.png\" alt=\"Moderate\n\n* Extensive skin or joint involvement\n* Plus or minus moderate cytopenia\n* Plus or minus additional organ involvement\n* No organ-threatening disease\n\nTreatment:\nHydroxychloroquine and glucocorticoid\n\nIf there is an adequate response: taper glucocorticoid\nIf there is an inadequate response: add additional immunosuppressive medication such as\n\n* Azathioprine or mycophenolate mofetil\n* Calcineurin inhibitor (for example, cyclosporine or tacrolimus)\" class=\"wp-image-5079\" srcset=\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/01\/image_e05534.png 975w, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/01\/image_e05534.png?resize=300,170 300w, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/01\/image_e05534.png?resize=768,436 768w\" sizes=\"auto, (max-width: 975px) 100vw, 975px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Major_Takeaway\"><\/span>Major Takeaway<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In <strong>moderate systemic lupus erythematosus (SLE)<\/strong> without <strong>organ-threatening disease<\/strong>, <strong>medium-dose oral glucocorticoids<\/strong> can be prescribed in addition to <strong>hydroxychloroquine<\/strong> to provide <strong>symptom relief<\/strong> and <strong>prevent disease progression.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"References\"><\/span>References<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400-1412. doi:10.1002\/art.40930<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Want_to_learn_more_about_this_topic\"><\/span>Want to learn more about this topic?<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Watch the Osmosis video: <a href=\"https:\/\/www.osmosis.org\/learn\/Systemic_lupus_erythematosus\">Systemic lupus erythematosus<\/a><\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><a href=\"https:\/\/www.osmosis.org\/plans\/pa\"><img loading=\"lazy\" decoding=\"async\" width=\"498\" height=\"178\" src=\"https:\/\/hm-healthdigital-multisite.go-vip.net\/osmosisblog\/wp-content\/uploads\/sites\/2\/2025\/02\/PA_4f31ab.png\" alt=\"\" class=\"wp-image-5469\" style=\"width:590px;height:auto\" srcset=\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PA_4f31ab.png 498w, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PA_4f31ab.png?resize=300,107 300w\" sizes=\"auto, (max-width: 498px) 100vw, 498px\" \/><\/a><\/figure>\n\n\n\n<p class=\"has-text-align-left wp-block-paragraph\"><em>Access your\u00a0<a href=\"https:\/\/www.osmosis.org\/login?type=create\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>free trial<\/strong><\/a>\u00a0now to discover why millions of current and future clinicians and caregivers love <strong>learning with us<\/strong><\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prepare for the PANCE with this challenging clinical scenario that tests your ability to diagnose and manage a common yet serious condition.\u00a0Devise a stepwise, evidence-based approach to treating an adult with systemic lupus erythematosus, including hydroxychloroquine, NSAIDs, glucocorticoids, and other immunomodulating agents, as well as ACE inhibitors and angiotensin receptor blockers.<\/p>\n","protected":false},"author":204,"featured_media":5100,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[20,38,1371,37,1366],"tags":[281,150,282,265,245,280,279,261,278,277],"class_list":["post-5078","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-exam-prep","category-pance","category-pance-questions","category-pa","category-questions","tag-chronic-illness-management","tag-clinical-practice","tag-evidence-based-practice","tag-healthcare-training","tag-nursing-education","tag-pance","tag-patient-assessment","tag-pharmacology","tag-systemic-lupus-erythematosus","tag-treatment-guidelines"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PANCE\u00ae Question of the Day: SLE management - Osmosis Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PANCE\u00ae Question of the Day: SLE management - Osmosis Blog\" \/>\n<meta property=\"og:description\" content=\"Prepare for the PANCE with this challenging clinical scenario that tests your ability to diagnose and manage a common yet serious condition.\u00a0Devise a stepwise, evidence-based approach to treating an adult with systemic lupus erythematosus, including hydroxychloroquine, NSAIDs, glucocorticoids, and other immunomodulating agents, as well as ACE inhibitors and angiotensin receptor blockers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\" \/>\n<meta property=\"og:site_name\" content=\"Osmosis Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-26T08:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-05T00:05:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\"},\"author\":{\"name\":\"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/0f19d5f5224a5dd5dde0670d5112696d\"},\"headline\":\"PANCE\u00ae Question of the Day: SLE management\",\"datePublished\":\"2025-02-26T08:01:00+00:00\",\"dateModified\":\"2025-11-05T00:05:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\"},\"wordCount\":788,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png\",\"keywords\":[\"chronic illness management\",\"clinical practice\",\"evidence-based practice\",\"healthcare training\",\"nursing education\",\"PANCE\",\"patient assessment\",\"pharmacology\",\"systemic lupus erythematosus\",\"treatment guidelines\"],\"articleSection\":[\"Exam Prep\",\"PANCE\",\"PANCE\",\"Physician Assistants\/Associates (PA)\",\"Questions of the Day\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\",\"url\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\",\"name\":\"PANCE\u00ae Question of the Day: SLE management - Osmosis Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png\",\"datePublished\":\"2025-02-26T08:01:00+00:00\",\"dateModified\":\"2025-11-05T00:05:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage\",\"url\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png\",\"contentUrl\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png\",\"width\":1080,\"height\":1080,\"caption\":\"PANCE Question of the Day SLE management\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.osmosis.org\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PANCE\u00ae Question of the Day: SLE management\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#website\",\"url\":\"https:\/\/www.osmosis.org\/blog\/\",\"name\":\"Osmosis Blog\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.osmosis.org\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#organization\",\"name\":\"Osmosis Blog\",\"url\":\"https:\/\/www.osmosis.org\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/07\/OsmosisElsevierStacked.png\",\"contentUrl\":\"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/07\/OsmosisElsevierStacked.png\",\"width\":1276,\"height\":596,\"caption\":\"Osmosis Blog\"},\"image\":{\"@id\":\"https:\/\/www.osmosis.org\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/0f19d5f5224a5dd5dde0670d5112696d\",\"name\":\"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9b0e629f7e0b8fc3e3200a26e9a1390c5c8099919b381c15b83bbcec2973f726?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9b0e629f7e0b8fc3e3200a26e9a1390c5c8099919b381c15b83bbcec2973f726?s=96&d=mm&r=g\",\"caption\":\"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD\"},\"description\":\"Authors: Rowan Bell, MD, Clinical Content Writer, Osmosis from Elsevier &amp; Marina Horiates Kerekes, MD, Director of Medical Assessment, Osmosis from Elsevier\",\"url\":\"https:\/\/www.osmosis.org\/blog\/author\/rowanbellandmarinahk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PANCE\u00ae Question of the Day: SLE management - Osmosis Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management","og_locale":"en_US","og_type":"article","og_title":"PANCE\u00ae Question of the Day: SLE management - Osmosis Blog","og_description":"Prepare for the PANCE with this challenging clinical scenario that tests your ability to diagnose and manage a common yet serious condition.\u00a0Devise a stepwise, evidence-based approach to treating an adult with systemic lupus erythematosus, including hydroxychloroquine, NSAIDs, glucocorticoids, and other immunomodulating agents, as well as ACE inhibitors and angiotensin receptor blockers.","og_url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management","og_site_name":"Osmosis Blog","article_published_time":"2025-02-26T08:01:00+00:00","article_modified_time":"2025-11-05T00:05:47+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","type":"image\/png"}],"author":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#article","isPartOf":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management"},"author":{"name":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","@id":"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/0f19d5f5224a5dd5dde0670d5112696d"},"headline":"PANCE\u00ae Question of the Day: SLE management","datePublished":"2025-02-26T08:01:00+00:00","dateModified":"2025-11-05T00:05:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management"},"wordCount":788,"commentCount":0,"publisher":{"@id":"https:\/\/www.osmosis.org\/blog\/#organization"},"image":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage"},"thumbnailUrl":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","keywords":["chronic illness management","clinical practice","evidence-based practice","healthcare training","nursing education","PANCE","patient assessment","pharmacology","systemic lupus erythematosus","treatment guidelines"],"articleSection":["Exam Prep","PANCE","PANCE","Physician Assistants\/Associates (PA)","Questions of the Day"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management","url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management","name":"PANCE\u00ae Question of the Day: SLE management - Osmosis Blog","isPartOf":{"@id":"https:\/\/www.osmosis.org\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage"},"image":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage"},"thumbnailUrl":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","datePublished":"2025-02-26T08:01:00+00:00","dateModified":"2025-11-05T00:05:47+00:00","breadcrumb":{"@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#primaryimage","url":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","contentUrl":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","width":1080,"height":1080,"caption":"PANCE Question of the Day SLE management"},{"@type":"BreadcrumbList","@id":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-sle-management#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.osmosis.org\/blog"},{"@type":"ListItem","position":2,"name":"PANCE\u00ae Question of the Day: SLE management"}]},{"@type":"WebSite","@id":"https:\/\/www.osmosis.org\/blog\/#website","url":"https:\/\/www.osmosis.org\/blog\/","name":"Osmosis Blog","description":"","publisher":{"@id":"https:\/\/www.osmosis.org\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.osmosis.org\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.osmosis.org\/blog\/#organization","name":"Osmosis Blog","url":"https:\/\/www.osmosis.org\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.osmosis.org\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/07\/OsmosisElsevierStacked.png","contentUrl":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/07\/OsmosisElsevierStacked.png","width":1276,"height":596,"caption":"Osmosis Blog"},"image":{"@id":"https:\/\/www.osmosis.org\/blog\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/0f19d5f5224a5dd5dde0670d5112696d","name":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.osmosis.org\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9b0e629f7e0b8fc3e3200a26e9a1390c5c8099919b381c15b83bbcec2973f726?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9b0e629f7e0b8fc3e3200a26e9a1390c5c8099919b381c15b83bbcec2973f726?s=96&d=mm&r=g","caption":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD"},"description":"Authors: Rowan Bell, MD, Clinical Content Writer, Osmosis from Elsevier &amp; Marina Horiates Kerekes, MD, Director of Medical Assessment, Osmosis from Elsevier","url":"https:\/\/www.osmosis.org\/blog\/author\/rowanbellandmarinahk"}]}},"jetpack_featured_media_url":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/02\/PANCE_QotD_SLE1_Q1_2025_SM.png","jetpack-related-posts":[{"id":3336,"url":"https:\/\/www.osmosis.org\/blog\/usmle-step-1-question-of-the-day-bilateral-pitting-ankle-edema","url_meta":{"origin":5078,"position":0},"title":"USMLE\u00ae Step 1 Question of the Day: Bilateral Pitting Ankle Edema","author":"Marina Horiates Kerekes, MD &amp; Team","date":"March 31, 2021","format":false,"excerpt":"Each week, Osmosis shares a USMLE\u00ae Step 1-style practice question to test your knowledge of medical topics. Today's case involves a 38-year-old woman with pain in the center of her chest. The pain is slightly better when she sits up straight. Physical examination shows conjunctival pallor and bilateral pitting ankle\u2026","rel":"","context":"In &quot;Allopathic Medicine (MD)&quot;","block_context":{"text":"Allopathic Medicine (MD)","link":"https:\/\/www.osmosis.org\/blog\/category\/medicine"},"img":{"alt_text":"USMLE\u00ae Step 1 Question of the Day: Bilateral Pitting Ankle Edema","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/2024-09-18T112652.031.webp","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/2024-09-18T112652.031.webp 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/2024-09-18T112652.031.webp 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/2024-09-18T112652.031.webp 2x"},"classes":[]},{"id":9086,"url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-hemoptysis","url_meta":{"origin":5078,"position":1},"title":"PANCE\u00ae Question of the Day: Hemoptysis","author":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","date":"January 19, 2026","format":false,"excerpt":"A 45-year-old with productive cough, hemoptysis, and systemic symptoms presents with cavitary lung lesions. Recognize key clinical and imaging features to guide diagnosis.","rel":"","context":"In &quot;Exam Prep&quot;","block_context":{"text":"Exam Prep","link":"https:\/\/www.osmosis.org\/blog\/category\/exam-prep"},"img":{"alt_text":"PANCE Question of the Day: Hemoptysis","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/01\/PANCE-Question-of-the-Day-Hemoptysis.jpg","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/01\/PANCE-Question-of-the-Day-Hemoptysis.jpg 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/01\/PANCE-Question-of-the-Day-Hemoptysis.jpg 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/01\/PANCE-Question-of-the-Day-Hemoptysis.jpg 2x"},"classes":[]},{"id":1489,"url":"https:\/\/www.osmosis.org\/blog\/pance-review-essentials-the-osmosis-ultimate-guide","url_meta":{"origin":5078,"position":2},"title":"PANCE\u00ae Review Essentials: The Osmosis Ultimate Guide","author":"Fergus Baird, MA","date":"July 29, 2020","format":false,"excerpt":"The PANCE\u00ae exam is what stands between a physician assistant student and certification. This five-hour, 300-question exam covers the breadth of content a PA student learns in school.\u00a0 Though it can be challenging to study for the PANCE given the volume of content you\u2019re expected to know, Osmosis has a\u2026","rel":"","context":"In &quot;Exam Prep&quot;","block_context":{"text":"Exam Prep","link":"https:\/\/www.osmosis.org\/blog\/category\/exam-prep"},"img":{"alt_text":"PANCE\u00ae Review Essentials: The Osmosis Ultimate Guide","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/55.webp","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/55.webp 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/55.webp 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2024\/09\/55.webp 2x"},"classes":[]},{"id":10215,"url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-diabetic-ketoacidosis","url_meta":{"origin":5078,"position":3},"title":"PANCE\u00ae Question of the Day: Diabetic ketoacidosis","author":"Rowan Bell, MD","date":"June 22, 2026","format":false,"excerpt":"A patient with diabetic ketoacidosis improves clinically but remains acidotic and hypotensive. Can you identify the next best management step in this high-yield PANCE-style scenario?","rel":"","context":"In &quot;Exam Prep&quot;","block_context":{"text":"Exam Prep","link":"https:\/\/www.osmosis.org\/blog\/category\/exam-prep"},"img":{"alt_text":"PANCE\u00ae Question of the Day: Diabetic ketoacidosis","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/06\/PANCE-Question-of-the-Day-Diabetic-Ketoacidosis.jpg","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/06\/PANCE-Question-of-the-Day-Diabetic-Ketoacidosis.jpg 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/06\/PANCE-Question-of-the-Day-Diabetic-Ketoacidosis.jpg 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2026\/06\/PANCE-Question-of-the-Day-Diabetic-Ketoacidosis.jpg 2x"},"classes":[]},{"id":7916,"url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-confusion","url_meta":{"origin":5078,"position":4},"title":"PANCE\u00ae Question of the Day: Confusion","author":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","date":"October 6, 2025","format":false,"excerpt":"Review a clinical scenario highlighting features of delirium, assessment strategies, and distinctions from dementia and other cognitive disorders.","rel":"","context":"In &quot;Exam Prep&quot;","block_context":{"text":"Exam Prep","link":"https:\/\/www.osmosis.org\/blog\/category\/exam-prep"},"img":{"alt_text":"PANCE Question of the day confusion","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-confusion.png","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-confusion.png 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-confusion.png 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-confusion.png 2x"},"classes":[]},{"id":7921,"url":"https:\/\/www.osmosis.org\/blog\/pance-question-of-the-day-period-symptoms","url_meta":{"origin":5078,"position":5},"title":"PANCE\u00ae Question of the Day: Period symptoms","author":"Rowan Bell, MD &amp; Marina Horiates Kerekes, MD","date":"October 12, 2025","format":false,"excerpt":"Understand the clinical presentation of premenstrual disorders with an emphasis on PMDD, its symptoms, and how to distinguish it from other medical conditions.","rel":"","context":"In &quot;Exam Prep&quot;","block_context":{"text":"Exam Prep","link":"https:\/\/www.osmosis.org\/blog\/category\/exam-prep"},"img":{"alt_text":"PANCE Question of the day Period Symptoms","src":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-Period-Symptoms.jpg","width":350,"height":200,"srcset":"https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-Period-Symptoms.jpg 1x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-Period-Symptoms.jpg 1.5x, https:\/\/www.osmosis.org\/blog\/wp-content\/uploads\/sites\/2\/2025\/10\/PANCE-Question-of-the-day-Period-Symptoms.jpg 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/posts\/5078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/users\/204"}],"replies":[{"embeddable":true,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/comments?post=5078"}],"version-history":[{"count":26,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/posts\/5078\/revisions"}],"predecessor-version":[{"id":8833,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/posts\/5078\/revisions\/8833"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/media\/5100"}],"wp:attachment":[{"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/media?parent=5078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/categories?post=5078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.osmosis.org\/blog\/wp-json\/wp\/v2\/tags?post=5078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}